NeuroScientific Biopharmaceuticals Limited

ASX:NSB Stock Report

Market Cap: AU$5.1m

NeuroScientific Biopharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

NeuroScientific Biopharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Is NeuroScientific Biopharmaceuticals (ASX:NSB) In A Good Position To Deliver On Growth Plans?

May 25
Is NeuroScientific Biopharmaceuticals (ASX:NSB) In A Good Position To Deliver On Growth Plans?

Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth

Jan 27
Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth

NeuroScientific Biopharmaceuticals (ASX:NSB) Is In A Good Position To Deliver On Growth Plans

Oct 07
NeuroScientific Biopharmaceuticals (ASX:NSB) Is In A Good Position To Deliver On Growth Plans

Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Can Afford To Invest In Growth

Jun 23
Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Can Afford To Invest In Growth

Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth

Mar 10
Companies Like NeuroScientific Biopharmaceuticals (ASX:NSB) Are In A Position To Invest In Growth

We're Hopeful That NeuroScientific Biopharmaceuticals (ASX:NSB) Will Use Its Cash Wisely

Nov 18
We're Hopeful That NeuroScientific Biopharmaceuticals (ASX:NSB) Will Use Its Cash Wisely

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if NSB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NSB's dividend payments have been increasing.


Dividend Yield vs Market

NeuroScientific Biopharmaceuticals Dividend Yield vs Market
How does NSB dividend yield compare to the market?
SegmentDividend Yield
Company (NSB)n/a
Market Bottom 25% (AU)2.7%
Market Top 25% (AU)6.3%
Industry Average (Biotechs)2.4%
Analyst forecast (NSB) (up to 3 years)n/a

Notable Dividend: Unable to evaluate NSB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NSB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate NSB's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as NSB has not reported any payouts.


Discover strong dividend paying companies